Characteristics of Covid-19 Disease in Multiple Sclerosis Patients

Characteristics of Covid-19 Disease in Multiple Sclerosis Patients Publisher Pubmed

Barzegar M^{1, 2} ; Mirmosayyeb O^{1, 2, 3} ; Ghajarzadeh M³ ; Nehzat N^{1, 3} ; Vaheb S¹ ; Shaygannejad V^{1, 2} ; Vosoughi R⁴

Show Affiliations

1. Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2. Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3. Universal Council of Epidemiology (UCE) Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran
4. University of Toronto, St. Michael's Hospital Multiple Sclerosis clinic, Toronto, ON, Canada

Source: Multiple Sclerosis and Related Disorders Published:2020

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. Favorable Outcome After Covid-19 Infection in a Multiple Sclerosis Patient Initiated on Ocrelizumab During the Pandemic, Multiple Sclerosis and Related Disorders (2020)

2. The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations During the Covid-19 Pandemic, Biomolecules (2021)

3. Predictors of Catching Covid-19 Infection During Pandemic Stage in Patients With Multiple Sclerosis (Ms), International Journal of Preventive Medicine (2022)

4. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)

5. Covid-19 Among Patients With Multiple Sclerosis a Systematic Review, Neurology: Neuroimmunology and NeuroInflammation (2021)

6. Covid-19 Infection and Hospitalization Rate in Iranian Multiple Sclerosis Patients: What We Know by May 2021, Multiple Sclerosis and Related Disorders (2022)

7. Impact of the Covid-19 Pandemic on the Psychological Status and Cortisol Level of Multiple Sclerosis Patients, Neuropsychological Rehabilitation (2023)

8. The Prevalence of Covid-19 Infection in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Neurological Sciences (2021)

Experts (# of related papers)

View all Related Experts

Vahid Shaygannejad (5)

Fereshteh Ashtari (2)

Style	Citing Format
MLA	Barzegar M, et al.. "Characteristics of Covid-19 Disease in Multiple Sclerosis Patients." Multiple Sclerosis and Related Disorders, vol. 45, no. , 2020, pp. -.
APA	Barzegar M, Mirmosayyeb O, Ghajarzadeh M, Nehzat N, Vaheb S, Shaygannejad V, Vosoughi R (2020). Characteristics of Covid-19 Disease in Multiple Sclerosis Patients. Multiple Sclerosis and Related Disorders, 45(), -.
Chicago	Barzegar M, Mirmosayyeb O, Ghajarzadeh M, Nehzat N, Vaheb S, Shaygannejad V, Vosoughi R. "Characteristics of Covid-19 Disease in Multiple Sclerosis Patients." Multiple Sclerosis and Related Disorders 45, no. (2020): -.
Harvard	Barzegar M et al. (2020) 'Characteristics of Covid-19 Disease in Multiple Sclerosis Patients', Multiple Sclerosis and Related Disorders, 45(), pp. -.
Vancouver	Barzegar M, Mirmosayyeb O, Ghajarzadeh M, Nehzat N, Vaheb S, Shaygannejad V, et al.. Characteristics of Covid-19 Disease in Multiple Sclerosis Patients. Multiple Sclerosis and Related Disorders. 2020;45():-.
BibTex	@article{ author = {Barzegar M and Mirmosayyeb O and Ghajarzadeh M and Nehzat N and Vaheb S and Shaygannejad V and Vosoughi R}, title = {Characteristics of Covid-19 Disease in Multiple Sclerosis Patients}, journal = {Multiple Sclerosis and Related Disorders}, volume = {45}, number = {}, pages = {-}, year = {2020} }
RIS	TY - JOUR AU - Barzegar M AU - Mirmosayyeb O AU - Ghajarzadeh M AU - Nehzat N AU - Vaheb S AU - Shaygannejad V AU - Vosoughi R TI - Characteristics of Covid-19 Disease in Multiple Sclerosis Patients JO - Multiple Sclerosis and Related Disorders VL - 45 IS - SP - EP - PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract